“After 35 incredible years at Johnson & Johnson, I find myself reflecting on the remarkable journey we’ve experienced together,” Jones said on LinkedIn today.
“To my friends and partners throughout this journey, this isn’t a farewell — it’s simply a ‘see you later,'” he later continued, saying he was embarking on an “exciting new chapter of my life and professional journey.”
Jones tells MassDevice he’s retiring from the Johnson & Johnson medical device business. J&J MedTech and Jones would not say whether his replacement has been identified.
His last day at the company is Nov. 15, J&J said in an statement shared with MassDevice. “Larry has played a pivotal role in the digital transformation of our MedTech organization, and we thank him for his many contributions to the company.”
With more than $30 billion in annual sales, J&J MedTech is the world’s second-largest medical device business, according to Medical Design & Outsourcing‘s 2024 Medtech Big 100 ranking by revenue.
“Our dedication to patients, community, customers, and employees has always been an inspiration, and I am immensely proud of our accomplishments,” Jones wrote in his LinkedIn post. “Our success stands as a testament to the amazing global teams and leaders with whom I’ve collaborated, creating a family-like atmosphere that made every challenge worthwhile. … I carry with me countless cherished memories, stories, and experiences. Thank you so much.”
“I want to extend my heartfelt gratitude to my family for their steadfast support, especially to my wife-coach, whose love and encouragement have been invaluable,” he continued. “I also want to thank my dad for being a great, yet humble role model. He instilled in me a strong work ethic of commitment and grit.”
“As I embark on this exciting new chapter of my life and professional journey, I remain committed to using technology for good, advancing global health equity, and fighting chronic disease,” Jones concluded.
It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She stayed on as an advisor until February 2024 as Tim Schmid assumed leadership of the medical device business.
Medtech pay analysis: J&J CEO pay doubled in 2023; Former J&J MedTech leader’s comp also climbed
On his LinkedIn page, Jones said his recent success included “completion of a 3 year, $200mm global digital transformation initiative to drive lean business processes, cloud-based solutions, and integrated insights.”
“Currently, he is focused on driving digital surgery connectivity solutions for the company’s surgical robotics and machine learning platforms in Oncology, Orthopedics, Cardiovascular, and general surgery,” his LinkedIn page said.
Earlier this month, J&J submitted its Ottava surgical robot for FDA investigational device exemption (IDE), nearly three years after unveiling the six-armed system.
Medical Design & Outsourcing interview: J&J MedTech’s Larry Jones imagines the future of cloud-connected medical devices
This post was originally published on Oct. 31, 2024, and updated on Nov. 1 with more information from J&J MedTech.
